Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s proprietary Two-Step Bactronizing Process uses an advanced electrostatic spray system to deliver eco-responsible antimicrobial agents that eliminate bacteria, viruses, mold, fungi and VOCs. The process provides a residual antimicrobial coating for extended protection. Products are EPA registered and NSF approved; the technology has been used in residential, commercial and institutional settings for infection prevention and environmental health. No clinical drug trials—services are commercially deployed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bactronix.